Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001329863 | SCV001521412 | pathogenic | Thrombocythemia 1 | 2020-03-24 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Centre for Clinical Genetics and Genomic Diagnostics, |
RCV004720860 | SCV005328447 | pathogenic | not provided | 2024-08-13 | criteria provided, single submitter | clinical testing | |
Juno Genomics, |
RCV004796606 | SCV005418290 | pathogenic | Thrombocythemia 1; Primary myelofibrosis | criteria provided, single submitter | clinical testing | PM2_Supporting+PS3+PS4+PP4_Moderate |